Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Memmorex is a dietary supplement developed and marketed by Peak Health Foundation (also known as Peak Health). It is positioned as a wellness product within their Ayurvedic-inspired supplement line, which includes other consumer health products such as Athero, Accentus, and Kriya Hops. Memmorex is intended to support cognitive function and memory. Unlike pharmaceutical drug candidates, it does not have a publicly disclosed molecular target or a formal clinical development pipeline. The product is sold directly to consumers as a nutraceutical and lacks pharmaceutical-grade clinical validation or defined biological mechanisms in standard biotech literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Memmorex.